Page 139 - Read Online
P. 139
sustained virologic response to interferon alpha plus ribavirin therapy Gastroenterol Hepatol 2012;24:646-55.
in naive chronic hepatitis C patients. BMC Gastroenterol 2009;9:5. 24. Floreani A, Cazzagon N, Boemo DG, Baldovin T, Baldo V, Egoue J,
19. Yu JW, Sun LJ, Zhao YH, Kang P, Yan BZ. Impact of sex on Antoniazzi S, Minola E. Female patients in fertile age with chronic
virologic response rates in genotype 1 chronic hepatitis C patients hepatitis C, easy genotype, and persistently normal transaminases
with peginterferon alpha-2a and ribavirin treatment. Int J Infect Dis have a 100% chance to reach a sustained virological response. Eur J
2011;15:e740-6. Gastroenterol Hepatol 2011;23:997-1003.
20. Akram M, Idrees M, Zafar S, Hussain A, Butt S, Afzal S, Rehman IU, 25. Aziz H, Athar MA, Murtaza S, Irfan J, Waheed Y, Bilal I, Raza
Liaqat A, Saleem S, Ali M, Butt A. Effects of host and virus related A. Predictors of response to antiviral therapy in patients with
factors on interferon-α+ribavirin and pegylated-interferon+ribavirin chronic hepatitis C from Pakistani population. Chin Med J (Engl)
treatment outcomes in chronic Hepatitis C patients. Virol J 2011;8:234. 2011;124:1333-7.
21. Villela-Nogueira CA, Perez RM, de SegadasSoares JA, Coelho HSM. 26. Hayashi J, Kishihara Y, Ueno K, Yamaji K, Kawakami Y, Furusyo N,
Gamma-glutamyltransferase (GGT) as an independent predictive Sawayama Y, Kashiwagi S. Age-related response to interferon alfa
factor of sustained virologic response in patients with hepatitis C treatment in women vs men with chronic hepatitis C virus infection.
treated with interferon-alpha and ribavirin. J Clin Gastroenterol Arch Intern Med 1998;158:177-81.
2005;39:728-30. 27. Sezaki H, Suzuki F, Kawamura Y, Yatsuji H, Hosaka T, Akuta N,
22. Hu CC, Lin CL, Kuo YL, Chien CH, Chen SW, Yen CL, Lin CY, Kobayashi M, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Miyakawa Y,
Chien RN. Efficacy and safety of ribavirin plus pegylated interferon Kumada H. Poor response to pegylated interferon and ribavirin in
alfa in geriatric patients with chronic hepatitis C. Aliment Pharmacol older women infected with hepatitis C virus of genotype 1b in high
Ther 2013;37:81-90. viral loads. Dig Dis Sci 2009;54:1317-24.
23. Innes HA, Hutchinson SJ, Allen S, Bhattacharyya D, Bramley P, 28. Villa E, Cammà C, Di Leo A, Karampatou A, Enea M, Gitto S,
Carman B, Delahooke TE, Dillon JF, Goldberg DJ, Kennedy N, Mills Bernabucci V, Losi L, De Maria N, Lei B, Ferrari A, Vukotic R,
PR, Morris J, Morris J, Robertson C, Stanley AJ, Hayes P; Hepatitis Vignoli P, Rendina M, Francavilla A. Peginterferon-Α_2B plus
C Clinical Database Monitoring Committee. Ranking predictors ribavirin is more effective than peginterferon-Α_2A plus ribavirin
of a sustained viral response for patients with chronic hepatitis C in menopausal women with chronic hepatitis C. J Viral Hepat
treated with pegylated interferon and ribavirin in Scotland. Eur J 2012;19:640-9.
130 Hepatoma Research | Volume 2 | May 6, 2016